Muscle-Bone Imaging Core

肌肉骨骼成像核心

基本信息

项目摘要

ABSTRACT The Muscle-Bone Imaging Core (Core B) will support the research aims of all projects within this program project. The overall aim of the program project is to understand the mechanisms underlying crosstalk between muscle and bone that may contribute to the age related decline in muscle and bone mass and function. Another goal is to determine if muscle-bone crosstalk mediates some of the beneficial effects of exercise on the musculoskeletal system. This global question is addressed by each project from a different perspective, including: the effects of the muscle-derived factor, BAIBA, in old and young osteocytes (Project 1); the effects of osteocyte factors Wnt3a and PGE2/Wnt-β-catenin on muscle with aging (project 2); the role of extracellular vesicles in bone-muscle crosstalk with aging (Project 3); and estrogen receptor-mediated regulation of bone-muscle crosstalk with aging (Project 4). The Muscle-Bone Imaging Core will provide centralized imaging support and methodologies for all projects. This will include confocal and multiphoton 3D and live cell and intravital imaging of muscle and bone as well as histological preparation and staining of muscle tissues and mineralized tissues. It will also support quantitative histomorphometry and dynamic bone histomorphometry, immunohistochemistry, muscle fiber typing and 3D osteocyte confocal imaging as well as live imaging of mitochondrial dynamics and function. The core will standardize and integrate imaging techniques essential for all the projects in which muscle and bone phenotypes are being characterized as a function of age in transgenic mouse models with altered osteocyte or muscle function, as well as mice that have been subjected to exercise training. The Muscle-Bone Imaging Core is critical to the success and outcomes in all four projects. The technical expertise, instrumentation, quantitative analysis and standardized protocols of the Core will provide a centralized shared resource that will accelerate and enhance the research. Core B will coordinate its activities with the Animal Exercise and Analysis Core (Core C) to support the research aims of all the projects and to assist with characterizing the beneficial effects of exercise on the musculoskeletal system and how this is mediated by muscle-bone crosstalk. Successful completion of the research aims of these projects will provide new insight into why osteoporosis and sarcopenia occur together and may identify molecular mediators of common pathogenic mechanisms and of the beneficial effects of exercise, which may pave the way for development of new therapies. As muscle weakness contributes to falls that lead to fractures, new therapies addressing both aspects of this “muscle-bone loss syndrome” will improve quality of life and reduce mortality in the aged population.
摘要 肌肉-骨骼成像核心(核心B)将支持本计划项目中所有项目的研究目标。 该计划项目的总体目标是了解肌肉之间的串扰机制 以及可能导致与年龄相关的肌肉和骨骼质量和功能下降的骨骼。另一个目标是 以确定肌肉-骨骼串扰是否介导了运动对肌肉骨骼的一些有益影响, 系统每个项目都从不同的角度探讨这一全球性问题,包括: 老年和年轻骨细胞中的肌源性因子BAIBA(项目1);骨细胞因子Wnt 3a的作用 和PGE 2/Wnt-β-catenin在骨骼肌衰老中的作用(项目2);细胞外囊泡在骨-肌肉衰老中的作用 与衰老的相互作用(项目3);以及雌激素受体介导的骨-肌肉相互作用与衰老的调节 (项目4)。肌肉骨骼成像核心将为所有人提供集中的成像支持和方法 项目这将包括共焦和多光子3D和活细胞以及肌肉和骨骼的活体成像 以及肌肉组织和矿化组织的组织学制备和染色。它还将支持 定量组织形态计量学和动态骨组织形态计量学、免疫组织化学、肌纤维分型 和3D骨细胞共聚焦成像以及线粒体动力学和功能的实时成像。芯会 标准化和整合成像技术,这些技术对肌肉和骨骼表型 在骨细胞或肌肉发生改变的转基因小鼠模型中, 功能,以及已经进行运动训练的小鼠。肌肉骨骼成像核心是至关重要的 所有四个项目的成功和成果。技术专长,仪器,定量分析 核心的标准化协议将提供一个集中的共享资源, 加强研究。核心B将与动物运动和分析核心(核心C)协调其活动 支持所有项目的研究目标,并协助描述运动的有益效果 以及这是如何通过肌肉-骨骼串扰来介导的。成功完成 这些项目的研究目标将为骨质疏松症和肌肉减少症同时发生的原因提供新的见解 并且可以鉴定常见致病机制的分子介质和 运动,这可能为新疗法的发展铺平道路。由于肌肉无力导致福尔斯 新的治疗方法解决了这两个方面的“肌肉-骨骼损失综合症”将改善 提高老年人的生活质量和降低死亡率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SARAH L DALLAS其他文献

SARAH L DALLAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SARAH L DALLAS', 18)}}的其他基金

Leica Stellaris 8 Confocal Microscope System
Leica Stellaris 8 共焦显微镜系统
  • 批准号:
    10431037
  • 财政年份:
    2022
  • 资助金额:
    $ 20.83万
  • 项目类别:
Role of Extracellular Vesicles in Bone-Muscle Crosstalk with Aging
细胞外囊泡在衰老过程中骨-肌肉串扰中的作用
  • 批准号:
    10166745
  • 财政年份:
    2012
  • 资助金额:
    $ 20.83万
  • 项目类别:
Muscle-Bone Imaging Core
肌肉骨骼成像核心
  • 批准号:
    10413015
  • 财政年份:
    2012
  • 资助金额:
    $ 20.83万
  • 项目类别:
Osteocyte Control of Osteoblast Dynamics with Aging
骨细胞对衰老过程中成骨细胞动力学的控制
  • 批准号:
    8281074
  • 财政年份:
    2012
  • 资助金额:
    $ 20.83万
  • 项目类别:
Role of Extracellular Vesicles in Bone-Muscle Crosstalk with Aging
细胞外囊泡在衰老过程中骨-肌肉串扰中的作用
  • 批准号:
    10413019
  • 财政年份:
    2012
  • 资助金额:
    $ 20.83万
  • 项目类别:
Optimizing Normal Collagen Replacement in Osteogenesis Imperfecta
优化成骨不全患者的正常胶原蛋白替代
  • 批准号:
    8502630
  • 财政年份:
    2012
  • 资助金额:
    $ 20.83万
  • 项目类别:
Muscle/Bone Phenotyping Core
肌肉/骨骼表型核心
  • 批准号:
    8281057
  • 财政年份:
    2012
  • 资助金额:
    $ 20.83万
  • 项目类别:
Optimizing Normal Collagen Replacement in Osteogenesis Imperfecta
优化成骨不全患者的正常胶原蛋白替代
  • 批准号:
    8390315
  • 财政年份:
    2012
  • 资助金额:
    $ 20.83万
  • 项目类别:
Zeiss LSM 710 Confocal Microscopy System for Imaging of Mineralized Tissues
用于矿化组织成像的蔡司 LSM 710 共焦显微镜系统
  • 批准号:
    8050238
  • 财政年份:
    2011
  • 资助金额:
    $ 20.83万
  • 项目类别:
Dynamics of Assembly of Bone Matrix Proteins
骨基质蛋白组装动力学
  • 批准号:
    7871226
  • 财政年份:
    2009
  • 资助金额:
    $ 20.83万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20.83万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20.83万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.83万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了